Rock Springs Capital Management LP - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$67,074,010
-11.8%
2,710,061
+0.9%
1.80%
-0.7%
Q2 2023$76,072,249
+24.4%
2,686,167
+0.9%
1.81%
+24.1%
Q1 2023$61,137,067
-27.3%
2,661,605
-11.2%
1.46%
-28.0%
Q4 2022$84,144,303
-2.7%
2,996,592
-2.0%
2.02%
-9.4%
Q3 2022$86,477,000
+33.2%
3,057,869
+4.4%
2.23%
+18.3%
Q2 2022$64,924,000
-16.3%
2,928,458
+9.9%
1.89%
-3.3%
Q1 2022$77,586,000
-10.8%
2,665,275
+0.7%
1.95%
-2.8%
Q4 2021$86,995,000
-26.3%
2,646,625
+3.5%
2.01%
-19.0%
Q3 2021$117,968,000
-16.8%
2,556,179
-0.7%
2.48%
-11.6%
Q2 2021$141,870,000
+8.0%
2,574,308
+1.2%
2.80%
-2.2%
Q1 2021$131,352,000
+20.1%
2,543,600
+0.8%
2.87%
+23.6%
Q4 2020$109,344,000
+97.5%
2,523,521
+59.6%
2.32%
+65.1%
Q3 2020$55,353,000
-12.3%
1,581,509
+34.1%
1.40%
-18.9%
Q2 2020$63,091,000
+68.5%
1,179,720
+11.8%
1.73%
+11.8%
Q1 2020$37,449,000
+22.3%
1,055,500
+64.5%
1.55%
+59.9%
Q4 2019$30,632,000
+168.2%
641,500
+82.0%
0.97%
+112.7%
Q3 2019$11,421,000
+34.3%
352,500
+106.7%
0.46%
+47.7%
Q2 2019$8,505,000
+7.3%
170,500
+45.1%
0.31%
+0.7%
Q1 2019$7,924,000117,5000.31%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders